Literature DB >> 3954911

Treatment of paroxysmal supraventricular tachycardia with intravenous injection of adenosine triphosphate.

D Saito, M Ueeda, Y Abe, H Tani, T Nakatsu, H Yoshida, S Haraoka, H Nagashima.   

Abstract

Intravenous adenosine triphosphate rapidly terminated all 11 episodes of paroxysmal supraventricular tachycardia in 10 patients. Eight patients reported side effects but these resolved within 20 seconds and did not require treatment. Adenosine triphosphate is a suitable agent for the rapid termination of paroxysmal supraventricular tachycardia.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3954911      PMCID： PMC1232168          DOI： 10.1136/hrt.55.3.291

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  22 in total

1.  Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca2+ influx.

Authors:  J Schrader; R Rubio; R M Berne
Journal:  J Mol Cell Cardiol       Date:  1975-06       Impact factor: 5.000

2.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

Authors:  R A Spurrell; D M Krikler; E Sowton
Journal:  Br Heart J       Date:  1974-03

3.  [Adenosine triphosphate in paroxysmal tachycardia. Diagnostic and therapeutic volue].

Authors:  G Motté; M Waynberger; A Lebards; Y Bouvrain
Journal:  Nouv Presse Med       Date:  1972-12-16

4.  The chronotropic action of ATP and related compounds studied by direct perfusion of the sinus node.

Authors:  T N James
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

5.  [Death after intravenous application of isoptin].

Authors:  J Apitz; U Gaissmaier
Journal:  Med Klin       Date:  1971-05-14

6.  Effects of adenosine and ATP on AV conduction and on AV junctional rhythm.

Authors:  F Urthaler; T N James
Journal:  J Lab Clin Med       Date:  1972-01

7.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

Authors:  J P diMarco; T D Sellers; B B Lerman; M L Greenberg; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Physiological disposition of verapamil in man.

Authors:  M Schomerus; B Spiegelhalder; B Stieren; M Eichelbaum
Journal:  Cardiovasc Res       Date:  1976-09       Impact factor: 10.787

9.  The fast-slow form of atrioventricular nodal reentrant tachycardia in children.

Authors:  G S Wolff; R J Sung; A Pickoff; O L Garcia; R Werblin; P L Ferrer; D Tamer; H Gelband
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

10.  Effect of verapamil in infants with paroxysmal supraventricular tachycardia.

Authors:  J Soler-Soler; J Sagristá-Sauleda; A Cabrera; J Sauleda-Parés; J Iglesias-Berengué; G Permanyer-Miralda; J Roca-Llop
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690
View more
  3 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 2.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

3.  Dual control by ATP and acetylcholine of inwardly rectifying K+ channels in bovine atrial cells.

Authors:  D D Friel; B P Bean
Journal:  Pflugers Arch       Date:  1990-03       Impact factor: 3.657
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.